The travel vaccination service market is projected to reach USD 958.24 million by 2034, expanding from USD 527.84 million in 2025, at an annual growth rate of 6.85% during the forecast period from 2025 to 2034.

Travel Vaccination Service Market Statical Scope

Travel Vaccination Service Market Share, By Type

Reasons:

• Hepatitis Vaccine (28%) – Widely required for international travelers; higher prevalence and awareness drive dominance.
• Other (24%) – Includes multiple less common vaccines collectively forming a large share.
• Meningococcal Vaccine (18%) – Strong adoption due to mandatory requirements in certain regions (e.g., Hajj pilgrimage).
• Japanese Encephalitis Vaccine (12%) – Niche but significant for Asia-Pacific travelers.
• Yellow Fever Vaccine (10%) – Mandatory in many African/Latin American destinations.
• Cholera Vaccine (8%) – Lower uptake, mainly in endemic regions.

Travel Vaccination Service Market Share, By Application

Reasons:

• Individual (65%) – Largest share as most vaccines are taken by travelers personally before trips.
• Enterprise (25%) – Includes corporate-sponsored employee vaccination programs.
• Government Organization (10%) – Covers immunization programs for official/government travelers.

Travel Vaccination Service Market Share, By Region

Reasons:

• North America (30%) – High outbound travel rates and strong healthcare infrastructure.
• Europe (25%) – Significant international travel, strict regulations.
• Asia-Pacific (25%) – Increasing outbound travel, growth in tourism.
• Latin America & Middle East & Africa (10% each) – Smaller base but driven by regional disease prevalence and outbound tourism growth.

Travel Vaccination Service Market Companies

• Passport Health
• World Travel Care, LLC
• International Travel Clinic
• Capitol Travel Medicine
• Emory TravelWell
• Global Travel Clinics Houston
• Aurora Health Care

Travel Vaccination Service Market Segmentations

By Type

• Meningococcal Vaccine
• Japanese Encephalitis Vaccine
• Yellow Fever Vaccine
• Hepatitis Vaccine
• Cholera Vaccine
• Other

By Application

• Individual
• Enterprise
• Government Organization

By Region

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

List of Figures

• Global Market Overview
  • Figure 1: Global Travel Vaccination Market Size, 2024–2034 (USD Mn)
    – Depicts market growth from USD 494 Mn (2024) to USD 958.24 Mn (2034).
  • Figure 2: Global Travel Vaccination Market CAGR (2024–2034)
    – Shows CAGR of 6.85% over the forecast period.
• By Type
  • Figure 3: Market Share by Type, 2024 (%)
      – Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine, Other.
  • Figure 4: Market Share by Type, 2034 (%)
      – Forecasted distribution of each vaccine category in 2034.
  • Figure 5: Meningococcal Vaccine Market Size, 2024–2034 (USD Mn)
  • Figure 6: Japanese Encephalitis Vaccine Market Size, 2024–2034 (USD Mn)
  • Figure 7: Yellow Fever Vaccine Market Size, 2024–2034 (USD Mn)
  • Figure 8: Hepatitis Vaccine Market Size, 2024–2034 (USD Mn)
  • Figure 9: Cholera Vaccine Market Size, 2024–2034 (USD Mn)
  • Figure 10: Other Vaccines Market Size, 2024–2034 (USD Mn)
• By Application
  • Figure 11: Market Share by Application, 2024 (%)
      – Individual, Enterprise, Government Organization.
  • Figure 12: Market Share by Application, 2034 (%)
      – Forecast distribution of applications by 2034.
  • Figure 13: Individual Segment Market Size, 2024–2034 (USD Mn)
  • Figure 14: Enterprise Segment Market Size, 2024–2034 (USD Mn)
  • Figure 15: Government Organization Segment Market Size, 2024–2034 (USD Mn)
• By Region
  • Figure 16: Market Share by Region, 2024 (%)
      – North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
  • Figure 17: Market Share by Region, 2034 (%)
      – Forecast distribution of regions by 2034.
  • Figure 18: North America Market Size, 2024–2034 (USD Mn)
  • Figure 19: Europe Market Size, 2024–2034 (USD Mn)
  • Figure 20: Asia-Pacific Market Size, 2024–2034 (USD Mn)
  • Figure 21: Latin America Market Size, 2024–2034 (USD Mn)
  • Figure 22: Middle East & Africa Market Size, 2024–2034 (USD Mn)

List of Tables

• Global Market Overview
  • Table 1: Global Travel Vaccination Market, 2024 vs. 2034 (USD Mn, CAGR %)
  • Table 2: CAGR Comparison of Major Segments, 2024–2034
• By Type
  • Table 3: Market Segmentation by Type, 2024 (USD Mn & Share %)
      – Includes all 6 segments with calculated shares.
  • Table 4: Market Segmentation by Type, 2034 (USD Mn & Share %)
      – Forecast values and shares.
  • Table 5: Meningococcal Vaccine Market Size, 2024–2034 (USD Mn, CAGR %)
  • Table 6: Japanese Encephalitis Vaccine Market Size, 2024–2034 (USD Mn, CAGR %)
  • Table 7: Yellow Fever Vaccine Market Size, 2024–2034 (USD Mn, CAGR %)
  • Table 8: Hepatitis Vaccine Market Size, 2024–2034 (USD Mn, CAGR %)
  • Table 9: Cholera Vaccine Market Size, 2024–2034 (USD Mn, CAGR %)
  • Table 10: Other Vaccines Market Size, 2024–2034 (USD Mn, CAGR %)
• By Application
  • Table 11: Market Segmentation by Application, 2024 (USD Mn & Share %)
      – Individual, Enterprise, Government Organization.
  • Table 12: Market Segmentation by Application, 2034 (USD Mn & Share %)
  • Table 13: Individual Application Market Size, 2024–2034 (USD Mn, CAGR %)
  • Table 14: Enterprise Application Market Size, 2024–2034 (USD Mn, CAGR %)
  • Table 15: Government Organization Application Market Size, 2024–2034 (USD Mn, CAGR %)
• By Region
  • Table 16: Market Segmentation by Region, 2024 (USD Mn & Share %)
  • Table 17: Market Segmentation by Region, 2034 (USD Mn & Share %)
  • Table 18: North America Market Size, 2024–2034 (USD Mn, CAGR %)
  • Table 19: Europe Market Size, 2024–2034 (USD Mn, CAGR %)
  • Table 20: Asia-Pacific Market Size, 2024–2034 (USD Mn, CAGR %)
  • Table 21: Latin America Market Size, 2024–2034 (USD Mn, CAGR %)
  • Table 22: Middle East & Africa Market Size, 2024–2034 (USD Mn, CAGR %)